Co-beneldopa (Benserazide/levodopa) vs Rasagiline mesilate
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 5.1× as often as Rasagiline mesilate in April 2026 — 78,699 items versus 15,532 in England.
78,699items
Co-beneldopa (Benserazide/levodopa) · April 2026
NHSBSA Prescription Cost Analysis
15,532items
Rasagiline mesilate · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Rasagiline mesilate: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Rasagiline mesilate
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Rasagiline mesilate |
|---|---|---|
| Items, April 2026 | 78,699 | 15,532 |
| Items, last 12 months | 951,014 | 189,109 |
| Net ingredient cost, April 2026 | £966,679 | £41,466 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Rasagiline mesilate.